Case | Age | Gender | Steinbrocker | RA disease duration (yrs) | Previously used biologics | MTX (mg/week) | PSL (mg/day) | |
Stage | Class | |||||||
1 | 70 | F | IV | 4 | 9.6 | Naïve | 8 | 6 |
2 | 65 | F | IV | 3 | 33.0 | Naïve | 0 | 7 |
3 | 57 | M | III | 2 | 8.5 | ETN | 8 | 7 |
4 | 59 | M | III | 2 | 5.0 | Naïve | 8 | 5 |
5 | 51 | F | III | 2 | 0.5 | Naïve | 0 | 2.5 |
6 | 35 | M | II | 2 | 0.2 | Naïve | 8 | 5 |
7 | 68 | M | III | 3 | 1.6 | Naïve | 6 | 0 |
8 | 16 | F | III | 2 | 1.2 | Naïve | 0 | 0 |
9 | 43 | F | IV | 3 | 21.5 | Naïve | 0 | 0 |
10 | 68 | F | IV | 4 | 12.5 | IFX, ADA | 0 | 5 |
11 | 60 | F | IV | 3 | 37.0 | ADA | 8 | 0 |